HomeCompareALR vs PFE

ALR vs PFE: Dividend Comparison 2026

ALR yields 151.52% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALR wins by $26.24M in total portfolio value
10 years
ALR
ALR
● Live price
151.52%
Share price
$1.32
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.29M
Annual income
$11,439,609.73
Full ALR calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — ALR vs PFE

📍 ALR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALRPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALR + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALR pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALR
Annual income on $10K today (after 15% tax)
$12,878.79/yr
After 10yr DRIP, annual income (after tax)
$9,723,668.27/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, ALR beats the other by $9,701,348.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALR + PFE for your $10,000?

ALR: 50%PFE: 50%
100% PFE50/50100% ALR
Portfolio after 10yr
$13.17M
Annual income
$5,732,934.22/yr
Blended yield
43.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ALR
No analyst data
Altman Z
0.5
Piotroski
1/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALR buys
0
PFE buys
0
No recent congressional trades found for ALR or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALRPFE
Forward yield151.52%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$26.29M$49.6K
Annual income after 10y$11,439,609.73$26,258.71
Total dividends collected$24.35M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ALR vs PFE ($10,000, DRIP)

YearALR PortfolioALR Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$25,852$15,151.52$9,153$693.39+$16.7KALR
2$64,268$36,606.51$8,593$849.25+$55.7KALR
3$153,818$85,051.27$8,336$1,066.78+$145.5KALR
4$354,829$190,243.94$8,437$1,384.80+$346.4KALR
5$789,814$410,147.27$9,013$1,875.40+$780.8KALR
6$1,698,323$853,222.02$10,306$2,680.72+$1.69MALR
7$3,531,849$1,714,643.01$12,820$4,101.38+$3.52MALR
8$7,111,590$3,332,511.93$17,673$6,826.70+$7.09MALR
9$13,880,629$6,271,227.52$27,543$12,591.86+$13.85MALR
10$26,291,883$11,439,609.73$49,560$26,258.71+$26.24MALR

ALR vs PFE: Complete Analysis 2026

ALRStock

AlerisLife Inc. operates and manages senior living communities in the United States. It operates through two segments, Residential and Lifestyle Services. Its senior living communities comprise independent living communities, assisted living communities, memory care, continuing care retirement communities (CCRCs), skilled nursing facilities (SNFs), and an active adult community. The company offers nursing and healthcare services; and outpatient rehabilitation clinics and fitness services. As of December 31, 2021, it owned and operated or managed, 141 senior living communities located in 28 states with 20,105 living units, including 10,423 independent living apartments, 9,636 assisted living suites, which includes 1,872 of Bridge to Rediscovery memory care units, and one continuing CCRC, with 106 living units, including 46 SNF. The company was formerly known as Five Star Senior Living Inc. and changed its name to AlerisLife Inc. in January 2022. AlerisLife Inc. was incorporated in 2001 and is headquartered in Newton, Massachusetts.

Full ALR Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ALR vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALR vs SCHDALR vs JEPIALR vs OALR vs KOALR vs MAINALR vs JNJALR vs MRKALR vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.